In 265 adults having cardiac surgery, perioperative IV magnesium sulfate targeting 1.5–2.0 mmol/L did not reduce postoperative atrial fibrillation vs placebo (37.9% vs 28.6%; RR 1.29, 95% CI 0.92–1.80); trial stopped at interim analysis for futility.
RCTn = 265
Meerman et al. Magnesium Sulfate to Prevent Perioperative Atrial Fibrillation in Cardiac Surgery: A Randomized Clinical Trial